INFLUENCE OF REMOTE MONITORING OF IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR ON THE QUALITY OF LIFE OF PATIENTS
https://doi.org/10.25760/VA-2019-95-17-23
Abstract
Implantable cardioverters-defi brillators (ICD) are up-to-date sophisticated devices designed to decrease a risk of sudden cardiovascular death. Several studies have revealed that ICD implantation is associated with an improved quality of life in most subjects. The remote monitoring plays an important role in functioning of current ICDs. The contribution of remote monitoring of ICD activities to trends in quality of life is underestimated and has been inadequately investigated.
Aim: To assess the quality of life of patients with ICD depending on availability of the remote monitoring system with the aid of the SF-36 questionnaire (Medical Outcomes Study - Short Form).
Material and methods: One hundred and thirty-six patients with single-chamber and dual-chamber ICDs completed the questionnaire. Based on a availability of telemetric control of the implantable device, the patients were distributed into two groups. The remote monitoring group consisted in 71 subjects. In 65 patients, the control over the ICD function was performed without the system of remote monitoring only during visits to physicians. The subjects of both groups had similar clinical and demographic characteristics excluding the follow-up period duration. The quality of life was analyzed
using scores on 8 scales of the state of health of the SF-36 questionnaire.
Results: Availability of the remote monitoring system was associated with a signifi cant improvement of quality of life on the scales of physical functioning (p=0.013) and physical role functioning due to physical condition (p=0.008), bodily pain (p=0.018), general health perception (p=0.031), vitality (p=0.006), social functioning (p=0.035), and mental health (p=0.015). In whole, both physical and psychological components of health in the patients with remote monitoring were higher than those assessed in the offi ce (p=0.007 and p=0.019, respectively).
Conclusions: The quality of life of patients with ICDs with the function of telemetric control (remote monitoring) was signifi cantly higher according to almost all scales of the SF-36 questionnaire.
About the Authors
O. S. Trunova
ФГБУ «ФЦССХ» МЗ РФ, Пенза
Russian Federation
Russian Federation
S. S. Durmanov
ФГБУ «ФЦССХ» МЗ РФ, Пенза
Russian Federation
Russian Federation
V. V. Bazylev
ФГБУ «ФЦССХ» МЗ РФ, Пенза
Russian Federation
Russian Federation
References
1. Glikson M, Friedman PA. The implantable cardioverter defi brillator. // Lancet. 2001; 357(9262):1107-1117.
2. Moss AJ, Hall J, Cannon DS, et al. Improved survival with an implanted defi brillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defi brillator Implantation Trial Investigators. // The New England Journal of Medicine. 1996; 335: 1933-1940.
3. The Antiarrhythmics Versus Implantable Defi brillators (AVID) Trial Executive Committee. Are implantable cardioverter-defi brillators or drugs more effective in prolonging life? // The American Journal of Cardiology. 1997; 79: 661-663.
4. Greenberg H, Case RB, Moss AJ et al. Analysis of mortality events in the Multicenter Automatic Defi brillator Implantation Trial (MADIT-II). // Journal of the American College of Cardiology. 2004; 43: 1459-1465.
5. Tomzik J, Koltermann KC, Zabel M et al. Quality of life in patients with an implantable cardioverter defi brillator: a systematic review. // Front. Cardiovasc. Med. 2:34.
6. Sears S F, Conti J B. Quality of life and psychological functioning of ICD patient. // Heart. 2002; 87: 488-493.
7. Palacios-Ceña D, Losa-Iglesias ME, Alvarez-López C et al. Patients, intimate partners and family experiences of implantable cardioverter defi brillators: qualitative systematic review. // Journal of Advanced Nursing; 67(12): 2537-2550.
8. Burri H, Senouf D. Remote monitoring and follow-up of pacemakers and implantable cardioverter defi brillators. // Europace. 2009; 11(6): 701-709.
9. Ломидзе Н.Н., Хасанов И.Ш., Купцов В.В. Перспективы развития телемониторинга пациентов. // Вестник аритмологии. 2016; 83: 44-50.
10. Leppert F, Siebermair J, Martens E et al. Health Related Quality of Life and Device-Acceptance in Patients with Implantable Cardioverter-Defi brillators and Telemonitoring. // Value in Health. 2013; 16(7): 535-535.
11. Амирджанова В.Н, Коршунов Д.В., Ребров А.П., Сороцкая В.Н. Популяционные показатели качества жизни по опроснику SF-36 (результаты многоцентрового исследования качества жизни «МИРАЖ»). // Научно-практическая ревматология. 2008; 1: 36-48.
12. Базылев В.В., Шутов Д.Б., Асташкин А.Ф., Карнахин В.А. Разработка и внедрение методики проведения исследования качества медицинской помощи после кардиохирургического лечения с использованием опросника SF-36. // Вестник Росздравнадзора. 2016; 6: 67-73.
13. Клинические рекомендации ВНОА по проведению электрофизиологических исследований, катетерной абляции и применению имплантируемых антиаритмических устройств - М: ВНОА, 2017 - 702 c.
14. Dan D. Matlock, Big Brother Is Watching You. What Do Patients Think About ICD Home Monitoring? // Circulation. 2010; 122: 319-321.
15. Varma N., Epstein A. E., Irimpen A., Schweikert R., Love C. & TRUST Investigators. Effi cacy and Safety of Automatic Remote Monitoring for Implantable Cardioverter-Defi brillator Follow-Up. The Lumos-T Safely Reduces Routine Offi ce Device Follow-Up (TRUST) Trial. // Circulation. 2010; 122: 325-332.
16. Mabo P., Victor F., Bazin P. et al. Remote Monitoring for Follow-up of patients implanted with pacemaker: The First prospective randomized trial (COMPAS Trial). // Circulation. 2010; 122: 333-346.
17. Piorkowski C., Hindricks G., Taborsky M. et al. Home monitoring in MADIT II Patients: A Prospective Randomized Multicenter Comparison Against a Standard Follow-Up (REFORM Trial). // Circulation. 2006; 114: 749.
18. Hindricks G.; Varma N.; Kace S. et al. Daily remote monitoring of implantable cardioverter-defi brillators: insights from the pooled patient-level data from three randomized controlled trials (IN-TIME, ECOST, TRUST). // European Heart Journal. 2017; 38(22):1749-1755.
19. Горностаев А.А., Козлов А.В., Дурманов С.С., Базылев В.В. Желудочковые нарушения ритма после хирургической коррекции постинфарктных аневризм левого желудочка II-III типа по M. Di Donato - L. Menicanti у пациентов с фракцией выброса менее 30%. // Анналы аритмологии. 2016; 13(4): 222-229.
20. Slowiner D., Varma N.,G. Akar J. et al. HRS Expert Consensus Statement on remote interrogation and monitoring for cardiovascular implantable electronic devices. // Heart Rhythm. 2015; 12(7): 69-95.
21. Попылькова О.В., Дурманов С.С., Базылев В.В. Опыт работы сети «Сателлитных клиник» в системе удаленного мониторинга за пациентами с имплантированными кардиовертерами-дефибрилляторами. // Анналы аритмологии. 2016; 13: 183-188.
22. Бокерия Л.А., Ревишвили А.Ш, Суханов С.Г. и др. Влияние многокамерных имплантируемых кардиовертеров-дефибрилляторов на качество жизни больных с тахиаритмиями. // Пермский медицинский журнал. 2006; 2: 117-128.
23. Лебедева У.В., Лебедев Д.С. Психологические аспекты и качество жизни пациентов при хирургическом лечении аритмий. // Вестник аритмологии. 2005; 38: 23-28.
24. Francis J., Johnson B., Niehaus M. Quality of Life in Patients with Implantable Cardioverter Defi brillators. // Indian Pacing Electrophysiol. J. 2006; 6: 173-181.
25. Sim Ooi, Hong-Gu He, Yanhong Dong, Wenru Wang. Perceptions and experiences of patients living with implantable cardioverter defi brillators: a systematic review and meta-synthesis. // Health and Quality of Life Outcomes. 2016; 14: 160.
26. Humphreys NK, Lowe R, Rance J, Bennett PD. Living with an implantable cardioverter defi brillator: The patients’ experience. // Heart Lung. 2016; 45(1): 34-40.
27. McDonough A. The experiences and concerns of young adults (18-40 years) living with an implanted cardioverter defi brillator (ICD). // Eur J Cardiovasc Nurs. 2009; 8 (4): 274-80.
28. Morken IM, Severinsson E, Karlsen B. Reconstructing unpredictability: experiences of living with an implantable cardioverter defi brillator over time. // J Clin Nurs. 2010; 19: 537-46.
29. Verkerk AJ, Vermeer AM, Smets EM et al. Quality of life in young adult patients with a cardiogenetic condition receiving an ICD for primary prevention of sudden cardiac death. // Pacing Clin Electrophysiol. 2015; 38: 870-7.
30. Wallace RL, Sears SF Jr, Lewis TS et al. Predictors of quality of life in long-term recipients of implantable cardioverter defi brillators. // J Cardiopulm Rehabil. 2002; 22: 278-281.
31. Magnusson P., Mörner S., Gadler F., Karlsson J. Health-related quality of life in hypertrophic cardiomyopathy patients with implantable defi brillators. // Health and Quality of Life Outcomes. 2016; 14: 62.
32. Dunbar S., Dougherty C., Sears S. et al. Educational and Psychological Interventions to Improve Outcomes for Recipients of Implantable Cardioverter Defi brillators and Their Families. // Circulation. 2012; 126: 2146-2172.
33. Дармина Е.В., Илов Н.Н. Амбулаторное ведение больных с ИКД: тестирование в клинике или удаленный мониторинг // Сибирский Медицинский Журнал. 2017; 32(1): 84-86.
34. Duru F, Büchi S, Klaghofer R et al. How different from pacemaker patients are recipients of implantable cardioverter-defi brillators with respect to psychosocial adaptation, affective disorders, and quality of life? // Heart. 2001; 85: 375-379.
35. Sears SF, Todaro JF, Saia TL et al. Examining the psychosocial impact of implantable cardioverter defi brillators: a literature review // Clinical cardiology. 1999; 22: 481-489.
36. Herrmann C, von zur Muhen F, Schaumann A et al. Standardized assessment of psychological well-being and quality-of-life in patients with implanted defi brillators. Pacing // Clin Electrophysiol. 1997; 20: 95-103.
37. Carroll DL, Hamilton GA. Long-term effects of implanted cardioverter-defi brillators on health status, quality of life, and psychological state. // Am J Crit Care. 2008; 17(3): 222-230.
38. Williams AM, Young J, Nikoletti S, McRae S. Getting on with life: accepting the permanency of an implantable cardioverter defi brillator. // Int J Nurs Pract. 2007; 13(3): 166-172.
39. Palacios-Ceña D, Losa ME, Salvadores-Fuentes P et al. Experience of elderly Spanish men with an implantable cardioverter-defi brillator. // Geriatr Gerontol Int. 2011; 11(3): 320-327.
40. Saito N, Taru C, Miyawaki I. Illness experience: living with arrhythmia and implantable cardioverter defi brillator. // Kobe J Med Sci. 2012; 58(3): 72-81.
41. Flanagan JM, Carroll DL, Hamilton GA. The longterm lived experience of patients with implantable cardioverter defi brillators. // Med Surg Nurs. 2010; 19(2): 113.
Review
For citations:
Trunova O.S., Durmanov S.S., Bazylev V.V. INFLUENCE OF REMOTE MONITORING OF IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR ON THE QUALITY OF LIFE OF PATIENTS. Journal of Arrhythmology. 2019;26(1):17-23. (In Russ.) https://doi.org/10.25760/VA-2019-95-17-23
Views:
286
Email this article 